397 related articles for article (PubMed ID: 33786894)
41. Differential role of triggering receptors expressed on myeloid cells 2 R47H in 3 neurodegenerative diseases based on a systematic review and meta-analysis.
Zhang B; Li R; Zhang Y; Gao X
Medicine (Baltimore); 2020 Jan; 99(5):e18921. PubMed ID: 32000403
[TBL] [Abstract][Full Text] [Related]
42. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.
Guerreiro RJ; Lohmann E; Brás JM; Gibbs JR; Rohrer JD; Gurunlian N; Dursun B; Bilgic B; Hanagasi H; Gurvit H; Emre M; Singleton A; Hardy J
JAMA Neurol; 2013 Jan; 70(1):78-84. PubMed ID: 23318515
[TBL] [Abstract][Full Text] [Related]
43. TREM2 regulates innate immunity in Alzheimer's disease.
Li JT; Zhang Y
J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
[TBL] [Abstract][Full Text] [Related]
44. TREM2 rare variant p.R47H is not associated with Parkinson's disease.
Mengel D; Thelen M; Balzer-Geldsetzer M; Söling C; Bach JP; Schaeffer E; Herold C; Becker T; Liepelt I; Becker J; Riedel-Heller S; Scherer M; Jessen F; Maier W; Dodel R; Ramirez A
Parkinsonism Relat Disord; 2016 Feb; 23():109-11. PubMed ID: 26651418
[TBL] [Abstract][Full Text] [Related]
45. Targeting TREM2 for Parkinson's Disease: Where to Go?
Li XX; Zhang F
Front Immunol; 2021; 12():795036. PubMed ID: 35003116
[TBL] [Abstract][Full Text] [Related]
46. Neurodegenerative Disease-Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain.
Dean HB; Roberson ED; Song Y
Front Neurol; 2019; 10():1252. PubMed ID: 32021611
[TBL] [Abstract][Full Text] [Related]
47. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Wang X
Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
[TBL] [Abstract][Full Text] [Related]
48. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
[TBL] [Abstract][Full Text] [Related]
49. Elucidating the Role of TREM2 in Alzheimer's Disease.
Ulrich JD; Ulland TK; Colonna M; Holtzman DM
Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958
[TBL] [Abstract][Full Text] [Related]
50. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
[TBL] [Abstract][Full Text] [Related]
51. Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice.
Belloli S; Pannese M; Buonsanti C; Maiorino C; Di Grigoli G; Carpinelli A; Monterisi C; Moresco RM; Panina-Bordignon P
Neurobiol Aging; 2017 May; 53():159-168. PubMed ID: 28189343
[TBL] [Abstract][Full Text] [Related]
52. Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2).
Glebov K; Wunderlich P; Karaca I; Walter J
J Neuroinflammation; 2016 Jan; 13():17. PubMed ID: 26792193
[TBL] [Abstract][Full Text] [Related]
53. TREM2 ectodomain and its soluble form in Alzheimer's disease.
Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z
J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934
[TBL] [Abstract][Full Text] [Related]
54. TREM2 - a key player in microglial biology and Alzheimer disease.
Ulland TK; Colonna M
Nat Rev Neurol; 2018 Nov; 14(11):667-675. PubMed ID: 30266932
[TBL] [Abstract][Full Text] [Related]
55. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.
Walter J
J Biol Chem; 2016 Feb; 291(9):4334-41. PubMed ID: 26694609
[TBL] [Abstract][Full Text] [Related]
56. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; ; ; ; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):152-164. PubMed ID: 27899424
[TBL] [Abstract][Full Text] [Related]
57. The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes.
Ciani M; Bonvicini C; Scassellati C; Carrara M; Maj C; Fostinelli S; Binetti G; Ghidoni R; Benussi L
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405128
[TBL] [Abstract][Full Text] [Related]
58. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.
Ayer AH; Wojta K; Ramos EM; Dokuru D; Chen JA; Karydas AM; Papatriantafyllou JD; Agiomyrgiannakis D; Kamtsadeli V; Tsinia N; Sali D; Gylys KH; Agosta F; Filippi M; Small GW; Bennett DA; Gearing M; Juncos JL; Kramer J; Lee SE; Yokoyama JS; Mendez MF; Chui H; Zarow C; Ringman JM; Kilic U; Babacan-Yildiz G; Levey A; DeCarli CS; Cotman CW; Boxer AL; Miller BL; Coppola G
Alzheimer Dis Assoc Disord; 2019; 33(4):327-330. PubMed ID: 31513029
[TBL] [Abstract][Full Text] [Related]
59. The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics.
Lok HC; Kwok JB
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802612
[TBL] [Abstract][Full Text] [Related]
60. The role of neuroinflammation in dementias.
Pasqualetti G; Brooks DJ; Edison P
Curr Neurol Neurosci Rep; 2015 Apr; 15(4):17. PubMed ID: 25716012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
